Inclusion and exclusion criteria: Patients examined in our outpatient clinic for further work-up of presumed kidney damage were evaluated prospectively as previously published to examine the link between selenoprotein P, thyroid hormone, and renal impairment [28]. Thus, serum samples were drawn from July 2013 to July 2014. After centrifugation, serum samples were stored frozen (−80°) and analyzed between August 2014 and October 2014.

Reasons for study exclusion were previous known thyroid disorder requiring thionamides or levothyroxine treatment, and/or presence of antibodies against thyroid peroxidase, as well as medication with known or potential influence on thyroid hormone function (current or past intake of amiodarone, a high-dose steroid or furosemide, anticonvulsives, heparin, or estrogen-replacement therapy). Our local ethics committee approved the study. All patients gave informed consent to undergo testing and to be included in this pseudonymized analysis.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。